BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 17021277)

  • 1. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CANSURV: A Windows program for population-based cancer survival analysis.
    Yu B; Tiwari RC; Cronin KA; McDonald C; Feuer EJ
    Comput Methods Programs Biomed; 2005 Dec; 80(3):195-203. PubMed ID: 16257080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SAS macro for parametric and semiparametric mixture cure models.
    Corbière F; Joly P
    Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the proportion cured of cancer: some practical advice for users.
    Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
    Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A relative survival regression model using B-spline functions to model non-proportional hazards.
    Giorgi R; Abrahamowicz M; Quantin C; Bolard P; Esteve J; Gouvernet J; Faivre J
    Stat Med; 2003 Sep; 22(17):2767-84. PubMed ID: 12939785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric mixture model for analysing relative survival of patients with multiple cancers.
    Heinävaara S; Hakulinen T
    J Cancer Epidemiol Prev; 2002; 7(3):147-53. PubMed ID: 12665214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cure of cancer: a European perspective.
    Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
    Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible parametric models for relative survival, with application in coronary heart disease.
    Nelson CP; Lambert PC; Squire IB; Jones DR
    Stat Med; 2007 Dec; 26(30):5486-98. PubMed ID: 17893893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive and multiplicative covariate regression models for relative survival incorporating fractional polynomials for time-dependent effects.
    Lambert PC; Smith LK; Jones DR; Botha JL
    Stat Med; 2005 Dec; 24(24):3871-85. PubMed ID: 16320260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint models for multivariate longitudinal and multivariate survival data.
    Chi YY; Ibrahim JG
    Biometrics; 2006 Jun; 62(2):432-45. PubMed ID: 16918907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure fraction model with random effects for regional variation in cancer survival.
    Seppä K; Hakulinen T; Kim HJ; Läärä E
    Stat Med; 2010 Nov; 29(27):2781-93. PubMed ID: 20862662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel mixture cure models with random effects.
    Lai X; Yau KK
    Biom J; 2009 Jun; 51(3):456-66. PubMed ID: 19588451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian cure rate frailty models with application to a root canal therapy study.
    Yin G
    Biometrics; 2005 Jun; 61(2):552-8. PubMed ID: 16011704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, period and cohort effects in Bayesian smoothing of spatial cancer survival with geoadditive models.
    Sauleau EA; Hennerfeind A; Buemi A; Held L
    Stat Med; 2007 Jan; 26(1):212-29. PubMed ID: 16526007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian long-term survival model parametrized in the cured fraction.
    de Castro M; Cancho VG; Rodrigues J
    Biom J; 2009 Jun; 51(3):443-55. PubMed ID: 19572318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.